ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
May 11, 2021 18:18 JST
Source:
Zhong Ji Longevity Science Group Limited
中基長壽科學配股及發行認購股份集資總額達2.13億港元
擴大資本實力 捕捉長壽科學領域新機遇
香港, May 11, 2021 - (ACN Newswire) - 中基長壽科學集團有限公司(「中基長壽科學」,連同其附屬公司統稱「集團」;股份代號:0767.HK)宣佈,集團於2021年5月10日透過配售代理向不少於六名獨立承配人以配售價每股0.65港元配售最多2.5億股股份,集資最多達 2.13 億港元,為集團拓展長壽科學業務提供資金,為未來發展奠定穩固的基礎。
是次配售價每股0.65港元較5月10日收市價每股0.74港元折讓12.16%,而所有承配人均為獨立第三方。根據配售協定,承配人須就配售予彼等之配售股份遵守12個月禁售期。此次配售股份總數佔現時已發行股本約6.46%;假設已發行股本概無其他變動,經配發及發行配售股份擴大的公司已發行股本約6.07%。扣除將由集團承擔之配售相關費用及開支後,集資所得款項淨額預計將不少於2.07億港元,當中約1.8億港元主要用於集團發展長壽科學業務的收購項目,而其餘資金則用作集團往後之一般營運資金。
此外,中基長壽科學董事會主席兼執行董事閆立先生已與集團訂立認購協議,擬以相等於配售價的每股0.65港元認購集團配發及發行的合共7,700萬股股份,足證其對集團長遠可持續發展之信心及承諾。
中基長壽科學董事會主席兼執行董事閆立先生表示﹕「是次配售旨在為集團補充長期資金,擴大集團的資本實力,讓我們得以捕捉長壽科學領域的機遇,發掘潛質優厚的項目。此外,此舉亦可進一步擴大我們的股東基礎至一些優質及長遠的投資者。中基長壽科學現正加快發展步伐,完善我們的研發實力及產業鏈,目標為持份者爭取更大回報,實現集團『讓人類健康長壽』的願景。」
關於中基長壽科學集團有限公司
中基長壽科學集團有限公司(0767.HK)主要從事長壽科學、借貸、證券投資及投資諮詢業務。憑藉管理層在生物科技行業的專業知識及技術,集團近年銳意進軍國內長壽科學醫療行業,以嶄新的長壽管理方案實現 「讓人類健康長壽」的願景,透過長壽生物製品、細胞及基因療法,以及先進醫療等長壽科學技術,為人類的健康作出貢獻,從而建立良好聲譽。
有關更多資料,請瀏覽:
http://www.irasia.com/listco/hk/asiapacificsilkroad/
Source: Zhong Ji Longevity Science Group Limited
Sectors: Daily Finance, BioTech
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating
Apr 18, 2024 09:22 JST
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
Apr 17, 2024 16:17 JST
Honda Unveils Next-generation EV Series for China
Apr 17, 2024 12:15 JST
Lexus presents Time at the 2024 Milan Design Week
Apr 16, 2024 18:49 JST
Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA
Apr 16, 2024 14:36 JST
New circuit challenge for TOYOTA GAZOO Racing
Apr 15, 2024 17:21 JST
TOYOTA GAZOO Racing back on asphalt for Croatian challenge
Apr 12, 2024 19:36 JST
Heidelberg Materials North America Announces Latest Milestone in Edmonton CCUS Project
Apr 12, 2024 14:39 JST
MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors
Apr 11, 2024 18:08 JST
Mitsubishi Shipbuilding Acquires Approval in Principle (AiP) from Classification Society ClassNK for Ammonia Fuel Supply System (AFSS)
Apr 11, 2024 17:50 JST
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Apr 11, 2024 15:10 JST
Mitsubishi Corporation Announces Completion of Capital Raise by Nexamp
Apr 11, 2024 13:07 JST
Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine
Apr 10, 2024 16:55 JST
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Apr 10, 2024 13:36 JST
More Latest Release >>
Related Release
Zhong Ji Longevity Science Announces 2021 Interim Results
August 31 2021 09:36 JST
Zhong Ji Longevity Science Announces 2020 Annual Results
March 30 2021 23:15 JST
More Press release >>